Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
International Journal of Molecular Medicine|April 17, 2002
Frequent polymorphism of peroxisome proliferator activated receptor gamma gene in colorectal cancer containing wild-type K-ras geneShigeki Tomita, Hitoshi Kawamata, Johji Imura, et al.
Journal of Gastroenterology|February 1, 2003
A case of primary esophageal tuberculosis diagnosed by identification of Mycobacteria in paraffin-embedded esophageal biopsy specimens by polymerase chain reactionToshifumi Fujiwara, Yukio Yoshida, Shigeki Yamada, et al.
Oncology Reports|December 8, 2004
PTEN and p53 abnormalities are indicative and predictive factors for endometrial carcinomaFujiyuki Inaba, Hitoshi Kawamata, Tadahisa Teramoto, et al.
Anti-Cancer Drugs|July 11, 2003
Vesnarinone: a differentiation-inducing anti-cancer drugHitoshi Kawamata, Fumie Omotehara, Koh-ichi Nakashiro, et al.
Journal of Gastroenterology|July 12, 2002
Pathological issues of gastric and lower esophageal cancer: helicobacter pylori infection and its eradicationTakahiro Fujimori, Hitoshi Kawamata, Kazuhito Ichikawa, et al.
Frontiers in Oral Health|June 29, 2026
Mandibular bone regeneration after marginal mandibulectomy for advanced MRONJ following denosumab discontinuation: a case reportWataru Kotani, Chonji Fukumoto, Toshiki Hyodo, et al.
Oncotarget|February 13, 2016
Overexpression of TSC-22 (transforming growth factor- β-stimulated clone-22) causes marked obesity, splenic abnormality and B cell lymphoma in transgenic miceDaisuke Uchida, Hitoshi Kawamata, Fumie Omotehara, et al.
International Journal of Surgical Pathology|May 3, 2005
Histopathological study of small (<2 cm) gastric carcinoma with signet-ring cell component: significance of the admixed glandular componentsYasuo Ohkura, Hitoshi Kawamata, Yoko Chibana, et al.
Anticancer Research|March 6, 2020
Troglitazone, a Selective Ligand for PPARγ, Induces Cell-cycle Arrest in Human Oral SCC CellsMasahiro Saito, Yuki Fujita, Nobuyuki Kuribayashi, et al.
Oral Oncology|September 19, 2003
Thiazolidinediones inhibit cell growth of human oral squamous cell carcinoma in vitro independent of peroxisome proliferator-activated receptor gammaKoh-ichi Nakashiro, Nasima Mila Begum, Daisuke Uchida, et al.
Pageof 7